K Number
K161828
Device Name
kneeEOS
Manufacturer
Date Cleared
2016-10-03

(90 days)

Product Code
Regulation Number
892.2050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
kneeEOS is a software indicated for assisting orthopedic surgeon in preoperative planning of knee orthopedic surgery. The software allows for overlaying of 3D/2D implants models on radiological images EOS based and 3D reconstruction of bones, and includes tools for performing measurements on the images or 3D model of bones, and for selecting and positioning the implant model. Clinical judgments and experience are required to properly use the software.
Device Description
kneeEOS 1.0 allows surgeons to perform preoperative surgical planning of total knee arthroplasties. The software provides surgical tools to analyze preoperative data, to set the resection levels, to position and size the femoral and tibial components and to evaluate the final alignment of the leg. The images displayed are x-rays from EOS System (K152788) and 3D model of the knee from sterEOS Workstation (K160914). kneeEOS also displays preoperative parameters and updated values of these parameters after planning. kneeEOS is accessible on any computer via ONEFIT Management System (Class I device - Product code LMD - 510(k) Exempt) that provides a secure internet interface and storage through authentication mechanisms.
More Information

No
The summary describes a software for preoperative planning with tools for measurements, implant overlay, and positioning. It does not mention any AI or ML capabilities, and explicitly states that clinical judgment is required.

No.
The device is a software for preoperative planning and does not directly treat or diagnose a condition.

No

The device is indicated for preoperative planning of knee orthopedic surgery, assisting in selecting and positioning implant models, rather than diagnosing a condition.

Yes

The device is explicitly described as "software indicated for assisting orthopedic surgeon in preoperative planning" and "allows surgeons to perform preoperative surgical planning". While it utilizes data from other medical devices (EOS System, sterEOS Workstation), the device itself is the software platform for planning and analysis. The performance studies section also focuses on "Software verification and validation testing".

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
  • kneeEOS Function: kneeEOS is a software designed for preoperative planning of knee orthopedic surgery. It uses radiological images and 3D bone reconstructions to assist surgeons in planning implant placement and measurements.
  • Lack of Specimen Analysis: The description of kneeEOS does not mention any analysis of biological specimens from the patient. Its function is based on processing medical images and 3D models.

Therefore, kneeEOS falls under the category of medical device software used for surgical planning, not an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

kneeEOS is a software indicated for assisting orthopedic surgeon in preoperative planning of knee orthopedic surgery. The software allows for overlaying of 3D/2D implants models on radiological images EOS based and 3D reconstruction of bones, and includes tools for performing measurements on the images or 3D model of bones, and for selecting and positioning the implant model. Clinical judgments and experience are required to properly use the software.

Product codes

LLZ

Device Description

kneeEOS 1.0 allows surgeons to perform preoperative surgical planning of total knee arthroplasties. The software provides surgical tools to analyze preoperative data, to set the resection levels, to position and size the femoral and tibial components and to evaluate the final alignment of the leg. The images displayed are x-rays from EOS System (K152788) and 3D model of the knee from sterEOS Workstation (K160914). kneeEOS also displays preoperative parameters and updated values of these parameters after planning. kneeEOS is accessible on any computer via ONEFIT Management System (Class I device - Product code LMD - 510(k) Exempt) that provides a secure internet interface and storage through authentication mechanisms.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

x-rays from EOS System (K152788) and 3D model of the knee from sterEOS Workstation (K160914).

Anatomical Site

knee

Indicated Patient Age Range

Not Found

Intended User / Care Setting

orthopedic surgeon / Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Software verification and validation testing were conducted and documentation was provided as recommended by FDA's Guidance for Industry and FDA Staff, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices". The software was considered as a "moderate" level of concern, since a failure or latent design flaw could directly result in minor injury to the patient or operator, or could indirectly result in minor injury to the patient or operator through incorrect or delayed information or through the action of a care provider.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K073714

Reference Device(s)

K152788, K160914, K160407

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a symbol that resembles three stylized human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

October 3, 2016

ONEFIT medical, Inc. % Mr. Julien Simon QA/RA Manager 18 Rue Alain Savary Besancon 25000 FRANCE

Re: K161828 Trade/Device Name: kneeEOS Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: August 29, 2016 Received: August 31, 2016

Dear Mr. Simon:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

1

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Robert Oels

Robert Ochs. Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

2

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.

510(k) Number (if known)

1 K161828

Device Name kneeEOS

Indications for Use (Describe)

kneeEOS is a software indicated for assisting orthopedic surgeon in preoperative planning of knee orthopedic surgery. The software allows for overlaying of 3D/2D implants models on radiological images EOS based and 3D reconstruction of bones, and includes tools for performing measurements on the images or 3D model of bones, and for selecting and positioning the implant model. Clinical judgments and experience are required to properly use the software.

Type of Use (Select one or both, as applicable)Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C)
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services

Food and Drug Administration

Office of Chief Information Officer

Paperwork Reduction Act (PRA) Staff

PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."

FORM FDA 3881 (8/14)Page 1 of 1PSC Publishing Services (301) 443-6740 EF
------------------------------------------------------------------------------

37

3

510(k) SUMMARY ONEFIT's kneeEOS

Submitter

ONEFIT medical, Inc.

18, rue Alain Savary 25000 Besançon France

Phone: +33(0) 3 81 25 24 27 Fax: +33(0) 3 81 25 53 51

Contact Person: Mr Julien SIMON, QA/RA Manager Date Prepared: June 30, 2016

Device

Name of Device: kneeEOS Classification Name: Picture Archiving and Communication System (21 CFR 892.2050) Regulatory Class: II Product Code: LLZ

Predicate Device

TraumaCad Release 2.0 (K073714) by ORTHOCRAT LTD.

Intended Use/Indications for Use

kneeEOS is a software indicated for assisting orthopedic surgeon in preoperative planning of knee orthopedic surgery. The software allows for overlaying of 3D/2D implants models on radiological images EOS based and 3D reconstruction of bones, and includes tools for performing measurements on the images or 3D model of bones, and for selecting and positioning the implant model. Clinical judgments and experience are required to properly use the software.

Device Description

kneeEOS 1.0 allows surgeons to perform preoperative surgical planning of total knee arthroplasties. The software provides surgical tools to analyze preoperative data, to set the resection levels, to position and size the femoral and tibial components and to evaluate the final alignment of the leg. The images displayed are x-rays from EOS System (K152788) and 3D model of the knee from sterEOS Workstation (K160914). kneeEOS also displays preoperative parameters and updated values of these parameters after planning. kneeEOS is accessible on any computer via ONEFIT Management System (Class I device - Product code LMD - 510(k) Exempt) that provides a secure internet interface and storage through authentication mechanisms.

4

Comparison of Technological Characteristics with the predicate device

Preoperative planning for knee surgery is the technological principle for kneeEOS and one of the possibilities offered by the predicate. The aim for these software is to provide to the surgeon realistic tools for simulating total knee arthroplasty.

kneeEOS 1.0 (ONEFIT medical, Inc.) and its predicate TraumaCad 2.0 (Orthocrat, Ltd.) are based on the same following technological elements:

  • Access to the software is secured and limited only to surgeons because personal data are stored in those software and surgical experience is required.

  • Use of x-ray images and preoperative parameters calculated from the patient's anatomy.

  • Use of the workflow to guide the surgeon through the steps of planning: observation, analysis and action.

  • An interface that allows for the maximum amount of information (including images) and tools, visible simultaneously on the same page.

  • Tools for improve visualization, to perform measurements, to choose, size and position implants, and to adjust the alignment of the leg.

  • Display values of preoperative parameters and updated values after planning.

The only differences between kneeEOS and its predicate are:

(1) kneeEOS claims compliance with standards EN ISO 14971:2012, IEC 62304:2006 and EN 62366:2008.

(2) Software and hardware minimum requirements for kneeEOS.

(3) kneeEOS input data comprise a 3D model of the knee.

(4) kneeEOS exports a PDF planning report.

(5) kneeEOS displays preoperative and planned values of parameters.

These differences do not present any new questions of safety or effectiveness because:

(1) These international standards are or have been recognized by the FDA. The standard on ability has recently been replaced by a new version, currently recognized by the FDA. However, the two versions claim similar principles on the development of the interface. Despite the lack of information on the subject for the predicate, there is no safety or efficiency question created by this difference, because these standards have also been used in the development of the latest FDA-approved software of ONEFIT medical: spineEOS (see Appendix [42] K160407_spineEOS). These three standards are intended to help reduce risk and errors in the software design.

(2) These requirements are not disproportionate to the computers currently on the market.

(3) This 3D model reconstruction is performed by sterEOS Workstation (K160914), which is a medical device already cleared by the FDA. All indications of use and operating procedures of sterEOS Workstation are respected. The software kneeEOS uses the sterEOS Workstation output data as input data without any prior modification.

(4) Both software allow to generate a report which contains all data from the planning. The difference lies in the format of generated reports (PDF/HTML): Most web browsers up to date include a PDF Reader and this format has the advantage of being more protected aqainst any changes that HTML page. This difference does not raise questions about safety or effectiveness in comparison to TraumaCad. All the information contained in this report can be found in the software. The generation of a planning report is also an available feature in kneeEOS (K160407).

5

(5) TraumaCad does not have distinct preoperative / planned steps; images are simply displayed and the user can perform measurements on the x-rays (preoperative measurements) or on templates superimposed on x-rays (planned parameters). In kneeEOS, these values (preoperative and after planning) are automatically displayed in the left column and on the xrays but the same information can be extracted from both software. These differences do not raise questions about safety or effectiveness in comparison to TraumaCad because kneeEOS measurements are calculated from anatomical points, which are positioned with sterEOS Workstation (K160914).

kneeEOS has the same intended use and similar indications, technological characteristics, and principles of operation as its predicate device. The minor technological differences between the kneeEOS and its predicate device raise no new issues of safety or effectiveness.

Performance Data

Software verification and validation testing were conducted and documentation was provided as recommended by FDA's Guidance for Industry and FDA Staff, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices". The software was considered as a "moderate" level of concern, since a failure or latent design flaw could directly result in minor injury to the patient or operator, or could indirectly result in minor injury to the patient or operator through incorrect or delayed information or through the action of a care provider.

Conclusions

The device has the same intended use, and similar indications for use, technological characteristics, and principles of operation as its predicate device. The minor differences between the device and its predicate device raise no new issues of safety or effectiveness. Performance data demonstrate that the kneeEOS is as safe and effective as its predicate TraumaCad Release 2.0 (K073714) and, thus, is substantially equivalent.